IL151877A0 - A process for producing imidazopyridine derivatives and a crystal form of an imidazopyridine derivative - Google Patents
A process for producing imidazopyridine derivatives and a crystal form of an imidazopyridine derivativeInfo
- Publication number
- IL151877A0 IL151877A0 IL15187701A IL15187701A IL151877A0 IL 151877 A0 IL151877 A0 IL 151877A0 IL 15187701 A IL15187701 A IL 15187701A IL 15187701 A IL15187701 A IL 15187701A IL 151877 A0 IL151877 A0 IL 151877A0
- Authority
- IL
- Israel
- Prior art keywords
- imidazopyridine
- producing
- crystal form
- derivative
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000092565 | 2000-03-30 | ||
PCT/JP2001/002620 WO2001074821A1 (fr) | 2000-03-30 | 2001-03-29 | Nouveau procede de production de derive d'imidazopyridine fondu et nouvelle forme cristalline |
Publications (1)
Publication Number | Publication Date |
---|---|
IL151877A0 true IL151877A0 (en) | 2003-04-10 |
Family
ID=18607880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15187701A IL151877A0 (en) | 2000-03-30 | 2001-03-29 | A process for producing imidazopyridine derivatives and a crystal form of an imidazopyridine derivative |
Country Status (17)
Country | Link |
---|---|
US (1) | US7049437B2 (fr) |
EP (1) | EP1270578A4 (fr) |
JP (1) | JP3481930B2 (fr) |
KR (1) | KR20020082898A (fr) |
CN (1) | CN1203073C (fr) |
AU (1) | AU2001244613A1 (fr) |
BR (1) | BR0109643A (fr) |
CA (1) | CA2403131A1 (fr) |
CZ (1) | CZ20023276A3 (fr) |
HK (1) | HK1054387A1 (fr) |
HU (1) | HUP0300580A3 (fr) |
IL (1) | IL151877A0 (fr) |
MX (1) | MXPA02009460A (fr) |
NO (1) | NO20024623L (fr) |
PL (1) | PL357672A1 (fr) |
WO (1) | WO2001074821A1 (fr) |
ZA (1) | ZA200207295B (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1250550C (zh) | 2001-07-16 | 2006-04-12 | 盐野义制药株式会社 | 脒衍生物的制备方法 |
JPWO2004078173A1 (ja) * | 2003-02-05 | 2006-06-08 | 塩野義製薬株式会社 | 溶出性の改善された錠剤 |
EP1653914A4 (fr) | 2003-08-12 | 2008-10-29 | 3M Innovative Properties Co | Composes contenant une structure imidazo a substitution oxime |
NZ545412A (en) | 2003-08-27 | 2008-12-24 | Coley Pharm Group Inc | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
CA2537763A1 (fr) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Traitement pour le lymphome a cellules b cd5<sp>+</sp> |
US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
BRPI0414856A (pt) | 2003-10-03 | 2006-11-21 | 3M Innovative Properties Co | imidazoquinolinas alcóxi-substituìdas |
CN1906193A (zh) | 2003-11-14 | 2007-01-31 | 3M创新有限公司 | 肟取代的咪唑环化合物 |
CA2545825A1 (fr) * | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Composes d'un anneau d'imidazo substitue par hydroxylamine |
MXPA06005910A (es) | 2003-11-25 | 2006-08-23 | 3M Innovative Properties Co | Sistemas de anillo imidazo sustituido y metodos. |
WO2005066170A1 (fr) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolines a substitution arylalcenyle et arylalkynyle |
JP2007517044A (ja) | 2003-12-30 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド |
AU2005228150A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
WO2005094770A1 (fr) * | 2004-03-30 | 2005-10-13 | Unilever Plc | Compositions pour eclaircir la peau comprenant des vitamines et des flavonoides |
US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
WO2006009832A1 (fr) * | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Systemes cycliques imidazo substitues, et procedes correspondants |
WO2006065280A2 (fr) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole |
US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
JP5313502B2 (ja) | 2004-12-30 | 2013-10-09 | スリーエム イノベイティブ プロパティズ カンパニー | 置換キラル縮合[1,2]イミダゾ[4,5−c]環状化合物 |
EP1831226B1 (fr) | 2004-12-30 | 2012-08-08 | 3M Innovative Properties Company | Composes chiraux tetracycliques incitant la biosynthese d'interferon |
US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
CA2597587A1 (fr) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes |
JP2008538550A (ja) | 2005-04-01 | 2008-10-30 | コーリー ファーマシューティカル グループ,インコーポレイテッド | ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物 |
AU2006232377A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
CA2623541A1 (fr) * | 2005-09-23 | 2007-03-29 | Coley Pharmaceutical Group, Inc. | Procede de preparation de 1h-imidazo[4,5-c]pyridines et d'analogues de ceux-ci |
US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
ES2966512T3 (es) | 2019-04-12 | 2024-04-22 | Blueprint Medicines Corp | Formas cristalinas de (S)-1-(4-fluorofenil)-1-(2-(4-(6-(1-metil-1H-pirazol-4-il)pirrolo[2,1-f][1,2,4]triazin-4-il)piperazinil)-pirimidin-5-il)etan-1-amina y métodos de elaboración |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378848A (en) * | 1992-02-12 | 1995-01-03 | Shionogi & Co., Ltd. | Condensed imidazopyridine derivatives |
IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
-
2001
- 2001-03-29 AU AU2001244613A patent/AU2001244613A1/en not_active Abandoned
- 2001-03-29 BR BR0109643-5A patent/BR0109643A/pt not_active IP Right Cessation
- 2001-03-29 MX MXPA02009460A patent/MXPA02009460A/es not_active Application Discontinuation
- 2001-03-29 CN CNB018073417A patent/CN1203073C/zh not_active Expired - Fee Related
- 2001-03-29 CZ CZ20023276A patent/CZ20023276A3/cs unknown
- 2001-03-29 KR KR1020027012412A patent/KR20020082898A/ko not_active Application Discontinuation
- 2001-03-29 PL PL01357672A patent/PL357672A1/xx not_active Application Discontinuation
- 2001-03-29 HU HU0300580A patent/HUP0300580A3/hu unknown
- 2001-03-29 IL IL15187701A patent/IL151877A0/xx unknown
- 2001-03-29 CA CA002403131A patent/CA2403131A1/fr not_active Abandoned
- 2001-03-29 US US10/239,785 patent/US7049437B2/en not_active Expired - Fee Related
- 2001-03-29 EP EP01917588A patent/EP1270578A4/fr not_active Withdrawn
- 2001-03-29 WO PCT/JP2001/002620 patent/WO2001074821A1/fr not_active Application Discontinuation
- 2001-03-29 JP JP2001572511A patent/JP3481930B2/ja not_active Expired - Fee Related
-
2002
- 2002-09-11 ZA ZA200207295A patent/ZA200207295B/en unknown
- 2002-09-26 NO NO20024623A patent/NO20024623L/no not_active Application Discontinuation
-
2003
- 2003-09-16 HK HK03106654.1A patent/HK1054387A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP3481930B2 (ja) | 2003-12-22 |
EP1270578A1 (fr) | 2003-01-02 |
AU2001244613A1 (en) | 2001-10-15 |
NO20024623L (no) | 2002-11-08 |
WO2001074821A1 (fr) | 2001-10-11 |
CZ20023276A3 (cs) | 2003-02-12 |
NO20024623D0 (no) | 2002-09-26 |
CA2403131A1 (fr) | 2001-10-11 |
US7049437B2 (en) | 2006-05-23 |
KR20020082898A (ko) | 2002-10-31 |
HUP0300580A2 (hu) | 2003-07-28 |
CN1419557A (zh) | 2003-05-21 |
EP1270578A4 (fr) | 2004-11-03 |
MXPA02009460A (es) | 2003-02-12 |
US20030088102A1 (en) | 2003-05-08 |
ZA200207295B (en) | 2003-09-11 |
HUP0300580A3 (en) | 2006-06-28 |
BR0109643A (pt) | 2003-04-22 |
CN1203073C (zh) | 2005-05-25 |
HK1054387A1 (zh) | 2003-11-28 |
PL357672A1 (en) | 2004-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL151877A0 (en) | A process for producing imidazopyridine derivatives and a crystal form of an imidazopyridine derivative | |
HUP0203851A3 (en) | Method for production of a triazolinethione derivative | |
IL155306A0 (en) | Methods for producing epothilone derivatives and analogs and epothilone derivatives and analogs produced thereby | |
IL154507A0 (en) | Process for making n-aryl-anthranilic acids and their derivatives | |
HK1089447A1 (en) | A process for the preparation of 2-aminocarbonyl-9h-purine derivatives and the intermediates thereof | |
HK1041883A1 (en) | Production of isoflavone derivatives | |
GB0007308D0 (en) | Process for preparing crystalline form | of cabergoline | |
IL146580A0 (en) | Method of producing nitroguanidine-and nitroenamine derivatives | |
AU2002222553A1 (en) | Process for producing anhydride of aminothiazole derivative | |
HUP0300475A3 (en) | Novel stable crystal of thiazolidinedione derivative and process for producing the same | |
HUP0302765A3 (en) | A process for the preparation of taxan derivatives | |
HUP0400686A3 (en) | Process and ester derivatives for preparation of cephalosporins | |
HUP0101875A3 (en) | Process for the preparation of piperidine derivatives | |
AU3734301A (en) | Method for producing 2-chloro-benzimidazole derivatives | |
HUP0203364A3 (en) | Method for preparation of 3-substituted-4-arylquinolin-2-one derivatives | |
HUP0201903A2 (en) | Benzofurane derivatives and process for producing them | |
HUP0303579A3 (en) | Process for preparing lipid ii and derivatives thereof | |
AU2002229149A1 (en) | Process for producing hydrazinomonosaccharide derivatives and use thereof | |
HUP0301141A3 (en) | Method for the production of trioxime derivatives | |
HUP0004469A3 (en) | Process for producing trifluormethyl-aniline derivatives | |
HUP0000208A3 (en) | Process for producing secondary-alkoxy-1-alkene derivatives | |
HUP0301741A3 (en) | Method for producing 4-bromine-aniline derivatives | |
AU2001269111A1 (en) | Method for producing 4-bromine-aniline derivatives | |
SI1296965T1 (sl) | Postopek za pripravo 4-brom-anilinskih derivatov | |
HUP0204270A3 (en) | Process for preparing cyclohexancarbonitrile derivatives and their intermediates |